Yukihiko Kimura < Yukihiko Saeki < Yukihiko Shirayama

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Yukihiko Saeki

Number of relevant bibliographic references: 6.

Ident.	Authors (with country if any)	Title
000D73 (2019)	Eri Oguro [Japon] ; Shiro Ohshima [Japon] ; Akie Kikuchi-Taura [Japon] ; Atsuko Murata [Japon] ; Kentaro Kuzuya [Japon] ; Yasutaka Okita [Japon] ; Hidetoshi Matsuoka [Japon] ; Satoru Teshigawara [Japon] ; Maiko Yoshimura [Japon] ; Yuji Yoshida [Japon] ; Kentaro Isoda [Japon] ; Eriko Kudo-Tanaka [Japon] ; Yoshinori Harada [Japon] ; Toshio Kaminou [Japon] ; Yukihiko Saeki [Japon]	Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression (DWIBS) as a Novel Imaging Modality for Disease Activity Assessment in Takayasu's Arteritis.
001098 (2018)	Takashi Shimizu ; Akie Kikuchi-Taura ; Soichiro Tsuji [Japon] ; Masato Matsushita [Japon] ; Shiro Ohshima ; Yukihiko Saeki	Up-regulation of CD64 Expression on Monocytes in Patients With Active Adult-Onset Still Disease: A Possible Biomarker of Disease Activity.
002359 (2014)	Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro Takagi	Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
002380 (2014)	Atsushi Ogata [Japon] ; Kazuhide Tanimura ; Toyohiko Sugimoto ; Hiroshi Inoue ; Yukitomo Urata ; Tsukasa Matsubara ; Masakazu Kondo ; Yukitaka Ueki ; Mitsuhiro Iwahashi ; Shigeto Tohma ; Shuji Ohta ; Yukihiko Saeki ; Toshio Tanaka	Phase III study of the efficacy and safety of subcutaneous versus intravenous tocilizumab monotherapy in patients with rheumatoid arthritis.
002460 (2014)	Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro Takagi	Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study.
003719 (2012)	Yukihiko Saeki [Japon] ; Eriko Kudo-Tanaka [Japon] ; Shiro Ohshima [Japon] ; Masato Matsushita [Japon] ; So-Ichiro Tsuji [Japon] ; Yu-Ichi Maeda [Japon] ; Maiko Yoshimura [Japon] ; Akane Watanabe [Japon] ; Yoshinori Katada [Japon] ; Yoshinori Harada [Japon] ; Kenji Ichikawa [Japon] ; Yasuo Suenaga [Japon] ; Yusuke Ohta [Japon] ; Shigeto Tohma [Japon]	Baseline anti-citrullinated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA)

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Yukihiko Saeki" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Yukihiko Saeki" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Yukihiko Saeki
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021